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1. Introduction
Optical neural stimulation is emerging as an exciting and more 
advantageous alternative to traditional electrical stimulation. 
The conductive nature of biological tissue leads to electrical 
current spread, limiting spatial resolution and preventing cell-
specific activation (Fenno et  al 2011, Warden et  al 2014). 
Genetic modification of neurons to express opsins, i.e. light-
sensitive proteins on neuronal membranes, renders neurons 
sensitive to light of a specific wavelength with millisecond 
precision (Boyden et  al 2005). In the last decade, optoge-
netics has been used extensively to modulate neural activity 
in the central nervous system (Deisseroth 2015). In 2016, a 
human trial of optogenetics to treat retinitis pigmentosa, a 
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Abstract
Objective. Nerves in the peripheral nervous system (PNS) contain axons with specific 
motor, somatosensory and autonomic functions. Optogenetics offers an efficient approach to 
selectively activate axons within the nerve. However, the heterogeneous nature of nerves and 
their tortuous route through the body create a challenging environment to reliably implant a 
light delivery interface. Approach. Here, we propose an optical peripheral nerve interface—an 
optocuff—, so that optogenetic modulation of peripheral nerves become possible in freely 
behaving mice. Main results. Using this optocuff, we demonstrate orderly recruitment of motor 
units with epineural optical stimulation of genetically targeted sciatic nerve axons, both in 
anaesthetized and in awake, freely behaving animals. Behavioural experiments and histology 
show the optocuff does not damage the nerve thus is suitable for long-term experiments. 
Significance. These results suggest that the soft optocuff might be a straightforward and 
efficient tool to support more extensive study of the PNS using optogenetics.
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degenerative disease in which the specialized light-sensitive 
photoreceptor cells in the eye die, was launched (clinicaltrials.
gov # NCT02556736).
The use of optogenetics in the peripheral nervous system 
(PNS) has to date been relatively modest, however, compared 
to optogenetic control in the brain (Jeschke and Moser 2015, 
Montgomery et al 2016), because of several physiologic and 
technological challenges. Peripheral nerves are complex, 
heterogeneous tissues embedded in muscle and connective 
tissue, which strongly scatter and absorb visible light. Nerves 
vary significantly in length and diameter, with small visceral 
nerves 100 times smaller than larger nerves, such as the sci-
atic nerve. Peripheral nerve stimulation is often conducted 
in awake, freely moving animals as anesthesia alters nerve 
excitability properties. Under normal physiologic conditions, 
peripheral nerves are stretched as joints move and muscles 
elongate, making consistent light delivery complex. Methods 
similar to those used in the brain can be used to express opsins 
in peripheral neurons; however several groups have reported 
on the difficulties in doing so with sufficient stability and effi-
cacy and without interfering with the regular function of the 
peripheral neurons (Miyashita et al 2013).
Controlled and long-term light delivery to peripheral nerves 
requires advances in neurotechnology to both enable long-
lasting and efficient opsin expression in specific subsets of 
axons in peripheral nerves and the production of implantable 
interfaces biointegrated with the flexible nerves and capable 
of sufficient light power delivery over extended periods of 
time without producing nerve damage.
In a pioneer study, Llewellyn et  al demonstrated that 
optical stimulation of motor units in a nerve of a transgenic 
mouse expressing the light-activated cation channel ChR2 in 
Thy1+ neurons better approximated physiological recruitment 
of motor fibers than electrical stimulation (Llewellyn et  al 
2010). For the first time, this study presented an optoelectronic 
implant for optical modulation of the sciatic nerve. However, 
the stiffness of the hybrid implant hosting 16 millimeter-side 
light emitting diodes (LEDs) limited its application to acute, 
anaesthetized conditions only.
Transdermal optical stimulation is a non-invasive alter-
native approach to optogenetic stimulation of peripheral 
sensory neurons. Excitation (Daou et al 2013, Arcourt et al 
2017, Browne et  al 2017) and inhibition (Iyer et  al 2014, 
Daou et  al 2016) of mouse primary afferent neurons have 
been demonstrated using such a design but efficient control 
of axon activation strongly depends on the optical properties 
of the intermediate tissues e.g. skin and subcutaneous tissue 
(Montgomery et  al 2016, Maimon et  al 2017). Effectively, 
stimulation is limited to nerve terminals in the skin whose 
superficial epidermal layers are innervated by nocicep-
tors. Direct optical stimulation of nerves using an implant 
is a promising approach for chronic PNS optogenetics. The 
question is how best to do this? The rapidly expanding use 
of optogenetics in the CNS has triggered development of a 
variety of optoprobes in the form of waveguide, miniaturized 
optical fibers and optoelectronic µLED-based arrays (Wu et al 
2013, Canales et al 2015, Fan and Li 2015, Alt et al 2017, Iseri 
and Kuzum 2017, Pisanello et al 2017) yet very few answer 
the technical needs for chronic peripheral nerve optogenetics.
Inspired by the report from Towne et al on an optical fiber-
based nerve cuff for optical stimulation in freely-behaving 
rats (Towne et al 2013), we have constructed a soft and bioin-
tegrated optocuff as an optical neural implant for chronic 
peripheral optogenetic stimulation in freely-behaving mice. 
The optocuff delivers blue light to axons expressing channel-
rhodopsin (ChR2) in transgenic mice. We overcame chronic 
implantation challenges with a miniaturized cuff design with 
soft materials and motion-compliant optic fibers. We dem-
onstrate optical muscle activation with epineural stimulation 
of Thy1 expressing motor axons and a stable nerve-implant 
interface after 20 d in vivo. This optocuff enables broad 
optogenetic neuromodulation of peripheral axons and is likely 
to contribute to the evaluation of using this strategy for new 
therapeutic interventions for the impaired PNS.
2. Methods
2.1. Mice
All mice were purchased from Jackson Laboratories and 
Thy1-Cre mice were backcrossed to C57BL/6 for at least 
five generations. Targeted expression of ChR2-tdTomato 
was achieved by breeding heterozygous Rosa-CAG-LSL-
hChR2(H134R)-tdTomato-WPRE (Ai27D) mice with 
Thy1-Cre mice. Resultant Thy1-Cre::ChR2 mice were hetero-
zygous for both transgenes and were housed with control lit-
termates. Mice were given ad libitum access to food and water 
and were housed in at 22  ±  1 °C, 50% relative humidity, and a 
12 h light:12 h dark cycle. Male and female mice were pooled 
by genotype to limit the number of animals used. All experi-
ments were conducted according to institutional animal care 
and safety guidelines and with IACUC approval at Boston 
Children’s Hospital, and accordance with Swiss federal leg-
islation and under the guidelines established at EPFL and 
approved by local Swiss Veterinary Offices.
2.2. DRG neuron culture and electrophysiology
Dorsal root ganglia neurons were isolated from adult (3–6 
month old) mice and maintained at 37 °C in 5% carbon dioxide. 
Electrophysiological recordings were made at 20–22 °C up to 
24 h after DRG neuron dissociation, using the whole-cell con-
figuration of the patch-clamp technique. Recording pipettes 
had tip resistances of 4–8 MΩ when filled with (in mM): 135 
K-gluconate, 10 KCl, 1 MgCl2, 5 EGTA, and 10 HEPES, pH 
7.3. The extracellular solution contained (in mM): 145 NaCl, 
5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, pH 
7.4. All solutions were maintained at 300–315 mOsm l−1. 
Membrane potential was recorded in current clamp mode with 
an Axopatch 200A amplifier and Digidata 1400A A/D inter-
face using pClamp 10.2 software (Molecular Devices). The 
data were low-pass filtered at 5 kHz (4-pole Bessel filter) and 
sampled at 10 kHz. Input resistance was typically  >500 MΩ, 
and cells with resistances  <200 MΩ were discarded. Care was 
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taken to maintain membrane access resistance as low as pos-
sible (usually 3–7 MΩ and always less than 10 MΩ). Detailed 
methods can be found in Browne et al (2017).
2.3. Nerve optical properties
Sciatic nerves of five naïve adult mice were carefully explanted 
after CO2 asphyxiation, immersed in PBS then embedded in 
2.5% agarose gel. Cross-sectional slices (100–1000 µm thick) 
were obtained with a vibratome apparatus (VTS1200, Leica) 
and mounted on microscopic glass slides (Superfrost, Thermo 
Scientific). A drop of saline was added to prevent slices from 
drying. Tissue transmittance was immediately measured with an 
optical system composed of a photodiode (S170C, Thorlabs), a 
power meter console (PM100D, Thorlabs) and a 473 nm DPSS 
laser (100 mW, LaserGlow) coupled to a multimode SMA optic 
fiber (105 µm core diameter, 1 m length, Thorlabs). The sensor 
was shaded with a mask matching nerve cross-section dimen-
sions and a constant intensity (15 mW · mm−2) illuminated the 
slices. The light radial distribution in sciatic nerve tissue was 
finally modeled using the modified 1D Beer–Lambert law:
I(z) = I0 ∗ e(−µeff ∗ z)
where I0 is the optic fiber output irradiance, µeff the effective 
attenuation coefficient and z the slice thickness (Al-Juboori 
et al 2013).
2.4. Optocuff construction
The cuff was built upon a polystyrene rod template (0.88 mm 
diameter, Evergreen). A soft 150 µm thick platinum-cata-
lyzed silicone (Ecoflex 00-50, Smooth-On) was vertically 
spin-coated and cured (2 h at 80 °C). A gold film was sput-
tered (80 nm, DP650, Alliance Concept) on the silicone to 
act as a light reflective coating. Finally, a micrometric film of 
Polydimethylsiloxane (PDMS) (Sylgard 184, Dow Corning) 
was used for encapsulation by spray deposition of a PDMS–
Heptane mixture. A 12 cm optic fiber (FG105UCA, 105 µm 
inner core diameter Thorlabs) was processed similarly to pre-
vious papers (Sparta et al 2011). Briefly, the acrylate coating 
tip-end of the fiber was dissolved in acetone and terminated 
with a 1.25 mm ceramic ferrule (CFLC128, Thorlabs). The 
fiber was then polished using a dedicated kit (Thorlabs) and 
its light transmission controlled with a power sensor. The 
distal end of the fiber was perpendicularly coupled to the 
cuff template and polymer sealed (Kwik-Sil, World Precision 
Instruments). Finally, the rod was carefully removed, the cuff 
trimmed (2 mm length, 0.8 mm inner diameter) and a sharp 
incision was applied transversally to the cuff. The compres-
sive stress built during elastomer curing caused the cuff to 
spontaneously fold spirally.
2.5. Optocuff implantation
All animal procedures were approved by the institutional 
animal care and safety guidelines and with IACUC approval 
at Boston Children’s Hospital. Healthy adult (3–6 month 
old) male and female Thy1-Cre::ChR2 mice of average mass 
27.5 g were implanted with the optical cuff. Mice were anes-
thetized under isoflurane (1–3%) and the body temperature 
was maintained with a heated surgical table (37 °C). The left 
hindlimb and head of the mouse were shaved and the skin 
disinfected using successive applications of betadine and 
isopropyl alcohol. Under sterile conditions, a skin incision 
exposed the skull, where 2 precision screws were drilled. 
The sciatic nerve was exposed at the mid-thigh level after 
a parallel 1 cm long skin incision and blunt muscles separa-
tion. The optical cuff and optic fiber were threaded subcu-
taneously, the ferrule end laying down the mouse skull and 
the cuff proximal to the sciatic nerve. A loop was formed on 
the optic fiber so the cuff has a 90° incidence angle on the 
sciatic nerve and to relieve the strain along the fiber after 
implantation. The cuff was then applied to wrap the sci-
atic nerve and a loose suture secured the optic fiber to sur-
rounding muscles. The separated muscles were sewed back 
together with absorbable sutures. The ferrule was anchored 
to the skull with a small amount of dental cement, and the 
incisions at the head and hindlimb closed with sutures (6-0, 
Ethicon). Full surgical procedure took 45 min. Control mice 
used in behavioural experiments underwent similar surgical 
procedure with the skull and sciatic nerve being exposed. 
Only a ferrule fixed on a 1 cm long optic fiber was mounted 
on the skull so blinded experimenters could not distinguish 
experimental groups. Mice were allowed to recover in single 
housed cage and subcutaneously injected with post-operative 
meloxicam analgesic for 3 d.
2.6. EMG electrode implantation and data acquisition
All surgical procedures were performed in accordance with 
Swiss federal legislation and under the guidelines established 
at EPFL and approved by local Swiss Veterinary Offices. The 
animals were administered general anesthesia (mixture of 
80 mg ml−1 ketamine, 10 mg ml−1 xylazine, diluted in saline), 
using intraperitoneal injections (8.5 ml kg−1). Bipolar intra-
muscular electrodes (AS632, Cooner Wire) were inserted 
unilaterally in the tibialis anterior (TA, ankle flexor) muscles 
to record electromyographic activity. Recording electrodes 
were created prior to implantation by removing a small part 
(~200 µm notch) of Teflon insulation. All the wires were 
connected to a percutaneous amphenol connector (Omnetics 
Connector Corporation). EMG recordings were synchronized 
with the laser stimulation onset using a custom-developed 
Tucker-Davis Technology (TDT) code. Signals were ampli-
fied (×1000) and pre-filtered (Bandpass: 100 Hz–1 kHz) with 
an AM systems amplifier.
2.7. Optogenetic control and high-speed behavioural imaging
The optical cuff was coupled to the laser with a multimode 
FC/PC optic fiber cable (105 µm core diameter, 2 m length, 
Thorlabs) using a ceramic mating sleeve (ADAL1, Thorlabs) 
on the ferrule. It was critical avoiding any physical stress on 
the mouse during the operation. Mice were housed in a small 
chamber (7.5  ×  7.5  ×  15 cm3) chambers and acclimatized 
for at least 30 min. A counter-balance lever arm (Harvard 
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Figure 1. Expression of ChR2 in the PNS of Thy1-Cre::ChR2+  mice. (A) Expression of ChR2-tdTomato in DRG soma was found in a 
broad class of neurons, myelinated (NF200+  , top left), CGRP+  (top right) and IB4+  (bottom left). White arrows indicate overlapping 
fluorescence emitting neurons. Scale bar 20 µm. ChR2 was expressed in a wide range of cell sizes as estimated using NeuN+  as a 
marker for all neurons (bottom right). (B) Expression of ChR2-tdTomato in sciatic nerve fibers. Scale bar 100 µm. Fluorescence was not 
observed in any of the littermate controls. (C) Whole-cell current clamp recordings of action potentials elicited by light in cultured ChR2-
tdTomato+  DRG neurons (17 neurons, 3 mice). These cells displayed a wide range of membrane capacitances and thresholds. Neurons 
from littermate controls did not show any effect of light (6 neurons). Light (473 nm for 3 ms) applied at 6 mW · mm−2.
Apparatus) relieved the mouse from the laser optic fiber cable 
weight. A computer-controlled pulse generator (OPTG-4, 
Doric) was used to supply TTL signals to the laser driver. 
Simultaneous epineural optogenetic stimulation (average 
40 mW laser output) and high-speed recordings were per-
formed. Behaviour was sampled at 1000 frames per second 
using an acA2040-180kmNIR cameralink CMOS camera 
(Basler) with a 8 mm lens and set at 500 pixels  ×  350 pixels. 
Acquisition was carried out in LabVIEW on a computer with 
excess buffer capacity to ensure all frames were successfully 
retained. Littermate control mice without Cre recombinase 
and implanted with the optical cuff did not react to blue light 
pulse (20 ms, 60 mW). Cuff implanted Thy1-Cre::ChR2 mice 
did not respond to an equivalent off-spectra pulse of light 
(594 nm, LaserGlow).
2.8. Behavioral experiments
All experiments were conducted in a quiet room at 22  ±  1 °C 
with 50% relative humidity. Animals were acclimatized to the 
behavioral testing apparatus during three habituation sessions 
in advance of starting the experiment. The behavioral tester 
was blinded until the experiment was complete.
2.8.1. Mechanical sensitivity. Mice were habituated, single 
housed in a small transparent chamber (7.5  ×  7.5  ×  15 cm3) 
elevated on a wire grid. Mechanical sensitivity was measured 
by applying an increasing perpendicular force to the lateral 
plantar surface of the left hindpaw using graded series of six von 
Frey filaments (with bending force of 0.04, 0.07, 0.16, 0.4, 0.6, 
1 g) and counting the number of withdrawal responses across 
ten applications. The pain mechanical threshold was defined as 
the minimal force triggering at least five withdrawals.
2.8.2. Thermal sensitivity. Each mouse was habituated on a 
warmed (29 °C) glass platform of a Hargreave’s apparatus 
(IITC Life Science). Thermal sensitivity was determined by 
applying a radiant heat source to the plantar hindpaw while 
measuring the duration before hindpaw withdrawal. The 
latency for the onset of nocifensive behavior was timed. This 
latency was determined three times per animal, per session, 
with a 5 min interval to prevent thermal sensitization.
2.8.3. Dynamic weight bearing. Mice inflammatory pain was 
assessed using a DWB test (Bioseb). Each mouse was placed 
5 min in a Plexiglas chamber (11  ×  19.7  ×  11 cm3) with a 
pressure transducers array on the floor. A camera recorded 
each movement while the mouse was exploring the chamber. 
Using a software matching pressure data and the video record-
ings, we discriminated and measured the weight (in grams) 
applied by the limbs. Finally, we extracted the duration of the 
cuff implanted hindpaw on the floor over the contralateral one.
2.8.4. Motor sciatic nerve assessment. Motor recovery in 
mice was assessed using a DigiGait apparatus (Mouse Spe-
cifics). Mice were recorded walking on the treadmill videog-
raphy system at 20 cm s−1. Measures of toe spread (TS) and 
the print length (PL, distance of the 3rd toe tip to the most 
posterior paw part) were used to calculate the sciatic nerve 
functional index (SFI) using the following formula (Baptista 
et al 2007):
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SFI = 118.9 ∗ (TSleft − TSright)
TSright
51.2 ∗ (PLleft − PLright)
PLright
7.5.
2.9. Tissue preparation and fluorescence imaging
Mice were anesthetized with pentobarbital (100 mg · kg−1 
intraperioneal) and fixed by transcardial perfusion with 4% 
paraformaldehyde dissolved in phosphate buffered saline 
(PBS). DRG (L3-L5) and sciatic nerves were dissected, post-
fixed, washed, cryoprotected with sucrose in PBS (30% w/v) 
for 2–3 d, and frozen (O.C.T., Tissue-Tek). Cryosections of 
DRG (10 µm thick) and sciatic nerves (10 µm longitudinal 
sections, 10 µm cross-sections) were blocked with 1% bovine 
albumin serum (BSA) and 0.1% triton X-100 in PBS for one 
hour. Sections were incubated with NF200 (1:2000), CGRP 
(1:500) primary antibody in fresh blocking solution overnight 
at 4 °C and washed three times (10 min each) in saline. They 
were then incubated with secondary IgG antibody (1:500, 
Life Technologies) for one hour at room temperature, washed 
three times (10 min each) in PBS, and mounted in Vectashield 
(H-1200). Fluorescein-conjugated GSL I was used at 1:1000. 
Finally, sciatic nerve cross-sections were incubated with 
DAPI (1:1000, 15 min, Sigma) and washed in PBS. DRG and 
sciatic nerve sections  were imaged using a Nikon Eclipse 
80i microscope using a Nikon 10×  objective and Nikon 
DS-Qi1MC camera. In DRG and sciatic nerves, fluorescence 
corresponding to tdTomato was absent in tissues from litter-
mate mice that did not express ChR2-tdTomato or that did not 
express the Cre recombinase.
3. Results
3.1. Functional expression of ChR2 in the PNS
The light-activated ion channel ChR2 was expressed in 
a broad class of sensory and motor neurons using a Cre-
recombinase transgenic approach (Campsall et  al 2002); 
Cre-dependent ChR2-tdTomato mice were crossed with 
Thy1-Cre driver mice. The resultant Thy1-Cre::ChR2 mice 
were heterozygous for both transgenes and ChR2 was found 
in dorsal root ganglion (DRG) neurons and in sciatic nerve 
axons (figures 1(A) and (B)). Of the ChR2+  DRG neurons, 
41% were myelinated (NF200), 4% were CGRP+  and 5% 
IB4+. Electrophysiological studies using whole-cell cur-
rent clamp recordings from ChR2-tdTomato+  DRG neurons 
showed action potentials were elicited by light (figure 1(C)). 
The large range of membrane capacitances ([11–51] pF; mean 
28±4 pF) and thresholds ([−56 to  −35] mV; mean  −44  ±  2 
mV) indicate a broad neuron population was targeted (Browne 
et  al 2017), as expected for the Thy1 promoter. Functional 
expression of ChR2 at the mid-axon enables an epineural 
light-delivery strategy.
Figure 2. Experimental system for optogenetic activation of the mouse PNS. (A) Optical stimulation carried out epineurally in Thy1-
Cre::ChR2 mice implanted with an optocuff. (B) Optical cuff illustration. A thin flexible optic fiber terminates on a silicone rubber-based 
cuff to deliver an optical stimulation on the mouse sciatic nerve. A gold thin film enables light to reflect internally. (C) Tensile strain-stress 
curves recorded from a fresh sciatic nerve immersed in physiological conditions and from the elastomeric cuff (n  =  1 per group). (D) 
Relative optical power transmission at 473 nm through fresh dissected sciatic nerve tissue (n  =  4 per thickness).
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3.2. A mouse soft, implantable optical cuff
We designed the optocuff as a soft, tubular construct that can 
be delicately wrapped around a mouse peripheral nerve, e.g. 
the sciatic nerve (figure 2(A)). Light is delivered to the cuff 
and the nerve via a flexible optic fiber (105 µm core) subcuta-
neously threaded from a miniaturized headstage and anchored 
to the cuff. Multilayers of soft silicones (25 kPa Young’s mod-
ulus) coated with a reflective thin gold film and a final PDMS 
film form the 2 mm long, 1 mm diameter cuff (figure 2(B)). The 
reflective metallic coating limits light spill to the surrounding 
tissues. The soft implant does not compress nor hinder the nat-
ural movement of the nerve as its elasticity surpasses that of 
the nerve (figure 2(C)).
We measured blue light transmission in vitro through slices 
of freshly dissected sciatic nerves. Light is rapidly absorbed 
with an effective attenuation coefficient µeff of 3.503 mm−1 at 
473 nm tissues (figure 2(D)). We measured an average of 16% 
optical power losses from the optic fiber to the optocuff such 
that sufficient light power can be delivered at the optocuff 
to excite opsin-carrying axons. Heating within the optocuff 
is limited to photon absorption, a significant advantage com-
pared to LED-based optoelectronic interfaces at analogous 
optical power (Yizhar et al 2011).
3.3. Orderly muscle recruitment to optical stimulation
To measure electromyographic (EMG) responses of anaes-
thetized Thy1::ChR2 mice to peripheral optical stimulation of 
motor axons the sciatic nerve of the mouse was exposed and 
implanted with the optocuff under general anesthesia (figure 
3(A)). Then, thin EMG electrodes were inserted into the ipsilat-
eral tibialis anterior (TA), an ankle flexor muscle innervated by 
the peroneal branch of the sciatic nerve. EMG recordings were 
synchronized with optical stimulation generated by an external 
473 nm laser. Short pulses of light consistently triggered uni-
lateral TA contractions, resulting in light-activated twitches. 
We characterized the muscle recruitment with the peak-to-peak 
value of EMG signal in the early phase of the response. We 
found the muscle fibers were recruited in an orderly fashion 
with the power of epineural irradiance of the optical stimulation 
(figures 3(B) and (C)). These results suggest more motor units 
were recruited with higher irradiance stimulation, consequently 
inducing larger muscle responses. Latency for the EMG onset 
(mean 6.1  ±  0.3 ms, 60 trials, 10 ms pulse width) was stable 
relative to the optical stimulation intensity and peak-to-peak 
amplitude (mean 6.1  ±  0.25 mV), implying direct activation of 
large and fast motor axons. The TA EMG amplitude directly 
correlated with optical pulse width (figure 3(D)), indicating an 
increased activation of motor neurons with longer pulses. These 
results demonstrate peripheral optogenetic modulation in anes-
thetized mice with the optocuff.
Next, we tested if the soft optocuff affects the sciatic nerve over 
time. We implanted a group of Thy1-Cre::ChR2 mice for 20 d 
with an optocuff wrapped around the left sciatic nerve; one end 
of the optic fiber was permanently anchored to its head-mounted 
ferrule. Histological cross-section of the nerve at the cuff site did 
Figure 3. Optical stimulation of the sciatic nerve in anaesthetized mice. (A) Optocuff implantation on the sciatic nerve. Scale bar 2 mm. 
(B)–(D) Optogenetic stimulation of peripheral axons in anaesthetized Thy1-Cre::ChR2 mice. Light-activated Tibialis Anterior EMG at 
various stimulation irradiances. The threshold for muscle contraction was 25 mW · mm−2 (B). The blue bar indicates the stimulation 
duration (10 ms). EMG amplitude is directly correlated with stimulation irradiance (C) and pulse width (D). (n  =  3 Thy1-Cre::ChR2 mice, 
5 trials per condition; irradiance set at 60 mW · mm−2).
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not show any sign of demyelination or signs of inflammation 
after the prolonged implantation (figures 4(A) and (B)). Coherent 
with this, sensory and motor behavioral assessments did not 
reveal any change at various times after implantation. Thermal 
and mechanical pain-related assays as well as weight bearing and 
gait were conducted prior and after surgery and did not reveal any 
significant change (p  >  0.05, ANOVA with Dunnett’s method).
3.4. Epineural stimulation of motor neuron axons in awake 
mice
Next, we tested whether the optocuff could reliably deliver 
epineural optical stimulation in awake, freely-behaving 
mice. We applied epineurally short (2–100 ms) light pulses 
at 473 nm with the optocuff while continuously monitoring 
the behavior of Thy1-Cre::ChR2 mice at 1 kHz with a camera 
(Basler Ace acA2040-180km). Optogenetic stimulation of 
the Thy1 axons resulted in short latency hindlimb muscle 
contraction (figures 5(A) and (B), Supp. V1 (stacks.iop.org/
JNE/15/015002/mmedia)). We observed global limb exten-
sion and paw opening with short (>5 ms) blue illumination. 
Probability of behavioural response to optical stimulation 
was higher with longer pulses (figure 5(C)) and reached 
100% for pulses longer than 20 ms. We found the delay for 
the change in behavior elicited by epineural stimulation 
was stable through different effective pulse duration (mean 
17.9  ±  0.58 ms, figure 5(D)). Using conduction velocity anal-
ysis, we concluded these changes in behavior were elicited by 
direct activation of motor neurons (Steffens et al 2012).
Furthermore, absence of response to optical stimulation 
carried with the optocuff in control littermate mice implies 
that light-responses were not caused by heat or visual artifact.
Figure 4. Histology and behavioural experiments reveals the optocuff is suitable for long-term implantation. (A) and (B) Sciatic nerve 
cross-sectional images 20 d following cuff implantation (A) or sham surgery (B). (C) and (D) Thermal (C) and mechanical (D) sensitivity 
assessed with Hargreaves and von Frey respectively, in cuff implanted (n  =  6) and control groups (n  =  3). Surgery was performed on day 0. 
(E) Dynamic weight bearing analysis of the duration of time spent on the ipsilateral versus the contralateral hindpaw, before surgery (white) 
and 5 d post-surgery (optocuff implantation) (grey). (F) Box plot representation of the functional sciatic index calculated gait analysis on 
treadmill (20 cm s−1).
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4. Discussion
We have developed an implantable optical interface that 
enables optogenetic modulation of the PNS in freely-behaving 
small animals such as mice. The soft optocuff can be wrapped 
around the sciatic nerve inducing minimal foreign body reac-
tion. Using transgenic Thy1-Cre::ChR2 mice, direct and 
robust muscle activation was obtained by optical stimulation 
of axons in the sciatic nerve, both in anaesthetized and awake 
animals. The muscular response can be finely tuned with the 
optical stimulation parameters i.e. pulse width and irradiance.
Stable light delivery to neurons/axons in vivo has been 
challenging, particularly for applications in the spinal cord 
or peripheral nerves (Montgomery et  al 2016). The relative 
motion of these soft biological tissues prevent long-term and 
reliable interface with the stiff implants. Although studies have 
bypassed this problem by stimulating nerve-endings via trans-
dermal illumination (Daou et al 2013, Iyer et al 2014, Arcourt 
et al 2017, Browne et al 2017) or using implanted wireless 
LEDs (Montgomery et al 2015, Park et al 2015), interfacing 
the whole nerve directly offers a broad range of opportunities. 
We find that reducing the mechanical mismatch between the 
nerve and implant and optimizing the surgical procedure were 
key for successful long-term optical coupling with the mouse 
PNS. The system relies on compliant, subcutaneously tethered 
fibers that enable a higher intensity and thermally safer light 
stimulation compared to optoelectronic systems. Additionally, 
the commercially available external light-sources allow for a 
large range of solutions for future optogenetic experiments.
Opsin expression in the mouse PNS was achieved using 
the transgenesis route. Although recent studies have exploited 
optogenetics in rats or primates (Klein et  al 2016, Pawela 
et al 2016, L et al 2017), mice are still the predominant spe-
cies used in the neurobiology field. This animal model pre-
sents obvious advantages for genetic manipulations, resulting 
in a large number of Cre-lines and Cre-dependent viral vectors 
available. We show that ChR2 opsin expression in PNS neurons 
was robust enough for optical modulation in vitro and in vivo. 
The optocuff system can be used for a wide variety of optoge-
netic experimental approaches, including activation as here and 
neural inhibition with opsins such as halorhodopsin (NpHr) or 
archaerhodopsin (Arch). Multi-spectra modulation using multi-
modal optic fibers will further broaden opportunities for the soft 
optocuff system (Berndt et al 2014, Chuong et al 2014).
Finally, long-term selective modulation of the PNS by light 
delivery offers new experimental opportunities. Optical stim-
ulation of peripheral axons has great implications for muscle 
control and nerve regeneration (Liske et al 2013, Bryson et al 
2014), for the study of sensory biology (Browne et al 2017) 
and for autonomic output (Kim et al 2015). Similarly, optoge-
netic inhibition in vivo will enable to tease out the functional 
role of specific neurons involve in complex disease mech-
anisms, such as tactile allodynia following nerve injury (Daou 
et al 2016).
Figure 5. Optogenetic control of peripheral neurons in awake behaving mice. (A) Behaviour sampled at 1 kHz elicited by a single pulse 
of light (50 ms, 40 mW · mm−2) applied to the sciatic nerve using the optocuff. Onset of the optical stimulation can be seen transdermally. 
Epineural optical stimulation of Thy1 axons in the sciatic nerve results in hindlimb muscle contraction and paw opening. (B) Motion 
detection reveals the kinetics of this behaviour. The latency to the response was 17 ms (supplementary video V1). This analysis was 
conducted by comparing the difference in pixel intensity between frames. (C) Probability of behavioural response to an epineural 
optogenetic stimulus depends on the pulse width (n  =  3 mice, 5 trials per condition). (D) Response latency upon epineural activation 
of Thy1 neurons demonstrates more stability with longer pulses. The mean latency did not depend on pulse duration (n  =  3 Thy1-
Cre::ChR2+  mice, 5 trials per condition). Littermate control cuff implanted mice did not show any response to light stimuli.
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In summary, soft optocuffs are a simple and efficient tool 
to probe the PNS with optogenetics. Its manufacturing does 
not require extensive microfabrication processes. Further 
miniaturization and addition of a wireless head-mounted light 
source would allow for an even broader use of the implant, 
especially to study smaller nerves, such as autonomic and vis-
ceral nerves (Birmingham et  al 2014). Finally, the optocuff 
system supports optogenetics as a versatile tool to unravel the 
PNS function, an essential step with therapeutic outcomes in 
many diseases, such as chronic pain.
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